Why the study?
Do antiarrhythmic agents (propranolol, quinidine, lidocaine, tetracaine) affect calcium uptake in canine cardiac sarcoplasmic reticulum in vitro?
Do antiarrhythmic agents (propranolol, quinidine, lidocaine, tetracaine) affect calcium uptake in canine cardiac sarcoplasmic reticulum in vitro?
Propranolol and quinidine inhibit calcium uptake in the cardiac sarcoplasmic reticulum, unlike lidocaine and tetracaine, suggesting their myocardial depressant effects may be linked to this mechanism rather than beta-blockade alone.
May link certain antiarrhythmics to SR calcium inhibition; hypothesis-generating for in vivo myocardial effects.
Fragmented cardiac sarcoplasmic reticulum was isolated by differential centrifugation from canine myocardium. The effects of propranolol, quinidine, lidocaine (lignocaine) and tetracaine (amethocaine) on calcium uptake in sarcoplasmic reticulum in vitro were then measured. All the drugs are antiarrhythmic agents with local anesthetic activity, but propranolol and quinidine are known also to have beta-receptor-blocking actions in that they can prevent the cardiac effects of isoprenaline and depress the myocardium. Lidocaine and tetracaine do not generally depress the heart and had no effect on the calcium uptake, but propranolol and quinidine both significantly inhibited it. It was concluded that the antiarrhythmic actions of propranolol (and quinidine) may be independent of beta-receptor-blocking activity, and that the safety of lidocaine as an antiarrhythmic agent may be related to a lack of effect on the sarcoplasmic reticulum.
No takes yet. Share an insight, caveat, or question.
Shinebourne et al. (1969) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: